BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8857208)

  • 1. Synthesis and antitumor activity evaluation of Delta2-1,2,4-oxadiazoline derivatives.
    Chimirri A; Grasso S; Monforte AM; Rao A; Zappala M
    Farmaco; 1996 Feb; 51(2):125-9. PubMed ID: 8857208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and characterization of platinum(II) oxadiazoline complexes and their in vitro antitumor activity in platinum-sensitive and -resistant cancer cell lines.
    Coley HM; Sarju J; Wagner G
    J Med Chem; 2008 Jan; 51(1):135-41. PubMed ID: 18072719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and anticancer activities of novel 3,5-disubstituted-1,2,4-oxadiazoles.
    Kumar D; Patel G; Johnson EO; Shah K
    Bioorg Med Chem Lett; 2009 May; 19(10):2739-41. PubMed ID: 19376704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and in vitro anti-HIV activity of novel delta 2-1,2,4-oxadiazoline derivatives.
    Chimirri A; Grasso S; Monforte AM; Monforte P; Zappalà M; Carotti A
    Farmaco; 1994; 49(7-8):509-11. PubMed ID: 7945718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of 1,2,5-oxadiazole N-oxide derivatives as hypoxia-selective cytotoxins.
    Monge A; López de Ceráin A; Ezpeleta O; Cerecetto H; Dias E; Di Maio R; González M; Onetto S; Seoane G; Suescun L; Mariezcurrena R
    Pharmazie; 1998 Nov; 53(11):758-64. PubMed ID: 9853357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An efficient synthesis and biological study of novel indolyl-1,3,4-oxadiazoles as potent anticancer agents.
    Kumar D; Sundaree S; Johnson EO; Shah K
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4492-4. PubMed ID: 19559607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, antimicrobial, and anti-HIV-1 activity of certain 5-(1-adamantyl)-2-substituted thio-1,3,4-oxadiazoles and 5-(1-adamantyl)-3-substituted aminomethyl-1,3,4-oxadiazoline-2-thiones.
    El-Emam AA; Al-Deeb OA; Al-Omar M; Lehmann J
    Bioorg Med Chem; 2004 Oct; 12(19):5107-13. PubMed ID: 15351394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New 6-cyano-3-phenyl-1-,2,3,4-tetrahydro-1,2-diazepin-5-ones: synthesis and in vitro antitumor activity evaluation.
    Dal Piaz V; Ciciani G; Giovannoni MP
    Farmaco; 1991 Mar; 46(3):435-47. PubMed ID: 1892501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antitumor activity evaluation of 1-[(arylidene)amino]adamantanes.
    Chimirri A; Gitto R; Grasso S; Monforte AM; Zappalà M
    Farmaco; 1994 Oct; 49(10):649-51. PubMed ID: 7826471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and in vitro antitumor activity of new quinoxaline derivatives.
    Corona P; Carta A; Loriga M; Vitale G; Paglietti G
    Eur J Med Chem; 2009 Apr; 44(4):1579-91. PubMed ID: 18774202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and cytotoxic evaluation of combretafurazans.
    Tron GC; Pagliai F; Del Grosso E; Genazzani AA; Sorba G
    J Med Chem; 2005 May; 48(9):3260-8. PubMed ID: 15857132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of new oxadiazoline-substituted naphthalenyl acetates as anticancer agents.
    Chaaban I; El Khawass el SM; Abd El Razik HA; El Salamouni NS; Redondo-Horcajo M; Barasoain I; Díaz JF; Yli-Kauhaluoma J; Moreira VM
    Eur J Med Chem; 2014 Nov; 87():805-13. PubMed ID: 25440882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel 4H-1,3,4-oxadiazin-5(6H)-ones with hydrophobic and long alkyl chains: design, synthesis, and bioactive diversity on inhibition of monoamine oxidase, chitin biosynthesis and tumor cell.
    Ke SY; Qian XH; Liu FY; Wang N; Yang Q; Li Z
    Eur J Med Chem; 2009 May; 44(5):2113-21. PubMed ID: 19027994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triazolo[4,5-f]quinolines. Part VI. Synthesis and evaluation of 9-aminoalkyl(aryl)-2-methyl-2H-[4,5-f]quinolines as anticancer agents. Preliminary results of in vitro screening.
    Sanna P; Sequi PA; Paglietti G
    Farmaco; 1995 Jan; 50(1):47-54. PubMed ID: 7702720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel 5-(2-hydroxyphenyl)-3-substituted-2,3-dihydro-1,3,4-oxadiazole-2-thione derivatives: promising anticancer agents.
    Aboraia AS; Abdel-Rahman HM; Mahfouz NM; El-Gendy MA
    Bioorg Med Chem; 2006 Feb; 14(4):1236-46. PubMed ID: 16242340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, structure, and bioactivity of N'-substituted benzylidene-3,4,5-trimethoxybenzohydrazide and 3-acetyl-2-substituted phenyl-5-(3,4,5-trimethoxyphenyl)-2,3-dihydro-1,3,4-oxadiazole derivatives.
    Jin L; Chen J; Song B; Chen Z; Yang S; Li Q; Hu D; Xu R
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5036-40. PubMed ID: 16876405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A facile synthesis of novel bis-(indolyl)-1,3,4-oxadiazoles as potent cytotoxic agents.
    Kumar D; Arun V; Maruthi Kumar N; Acosta G; Noel B; Shah K
    ChemMedChem; 2012 Nov; 7(11):1915-20. PubMed ID: 22997171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antitumour activity of a series of cyclic amidines of 2,3-dihydro-1H-1,5-benzodiazepines.
    Janciene R; Kosychova L; Bukelskiene V; Domkus V; Stumbreviciūte Z; Ragaleviciene V; Puodziūnaite BD
    Arzneimittelforschung; 2002; 52(6):475-81. PubMed ID: 12109049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of new 3-(3-phenyl-isoxazol-5-yl) or 3-[(3-phenyl-isoxazol-5-yl)-amino] substituted 4(3H)-quinazolinone derivatives with antineoplastic activity.
    Raffa D; Daidone G; Schillaci D; Maggio B; Plescia F
    Pharmazie; 1999 Apr; 54(4):251-4. PubMed ID: 10234736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro antitumor and antiviral activities of new benzothiazole and 1,3,4-oxadiazole-2-thione derivatives.
    Akhtar T; Hameed S; Al-Masoudi NA; Loddo R; La Colla P
    Acta Pharm; 2008 Jun; 58(2):135-49. PubMed ID: 18515224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.